Jennifer A Ligibel

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi request reprint Obesity and breast cancer
    Jennifer Ligibel
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA
    Oncology (Williston Park) 25:994-1000. 2011
  2. pmc Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance)
    Jennifer A Ligibel
    Dana Farber Cancer Institute, Boston, MA JAL, EW Alliance Statistics and Data Center, Durham, NC CTC Mayo Clinic, Rochester, MN ML, JNI Hofstra North Shore LIJ School of Medicine, ProHEALTH Care Associates, Lake Success, NY MC Northwestern University Feinberg School of Medicine, Chicago, IL WG The Angeles Clinic and Research Institute, Santa Monica, CA SM Rhode Island Hospital, Providence, RI WS St Barnabas Medical Center, Livingston, NJ RM The Genome Institute, Washington University in St Louis, St Louis, MO EM Department of Genetics, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC CMP Breast Cancer Program, Siteman Cancer Center and Washington University School of Medicine, St Louis, MO ME Memorial Sloan Kettering Cancer Center, New York, NY CAH Alliance Statistics and Data Center, MD Anderson Cancer Center, Houston, TX DB Alliance Statistics and Data Center, Dana Farber Cancer Institute, Boston, MA WTB
    J Natl Cancer Inst 107:. 2015
  3. doi request reprint Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology Statement
    Jennifer A Ligibel
    Jennifer A Ligibel and Elizabeth S Frank, Dana Farber Cancer Institute, Boston, MA Catherine M Alfano, Elvan C Daniels, and Kevin D Stein, American Cancer Society, Atlanta, GA Dawn Hershman, Columbia University Clifford A Hudis, Memorial Sloan Kettering Cancer Center, New York, NY Rachel M Ballard, National Institutes of Health Worta McCaskill Stevens and Lori M Minasian, National Cancer Institute, Bethesda, MD Suanna S Bruinooge and Laura A Levit, American Society of Clinical Oncology, Alexandria, VA Kerry S Courneya, University of Alberta, Edmonton, Alberta Pamela J Goodwin, University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada Wendy Demark Wahnefried, University of Alabama at Birmingham, Birmingham, AL Melinda L Irwin, Yale School of Public Health, New Haven, CT Mark A O Rourke, Greenville Hospital System, Greenville, SC John P Pierce, University of California San Diego Moores Cancer Center, San Diego, CA and Cynthia A Thomson, University of Arizona, Tucson, AZ
    J Clin Oncol 33:3961-7. 2015
  4. pmc American Society of Clinical Oncology position statement on obesity and cancer
    Jennifer A Ligibel
    Jennifer A Ligibel, Dana Farber Cancer Institute, Boston, MA Catherine M Alfano, National Cancer Institute, Bethesda, MD Kerry S Courneya, University of Alberta, Edmonton, Alberta, Canada Wendy Demark Wahnefried, University of Alabama at Birmingham, Birmingham, AL Robert A Burger, University of Pennsylvania, Philadelphia, PA Rowan T Chlebowski, Harbor University of California Los Angeles Medical Center, Torrance, CA Carol J Fabian, University of Kansas Medical Center, Westwood, KS Ayca Gucalp, Lee W Jones, and Clifford A Hudis, Memorial Sloan Kettering Cancer Center Dawn L Hershman, Columbia University Medical Center, New York, NY Melissa M Hudson and Kirsten K Ness, St Jude Children s Research Hospital, Memphis, TN Madhuri Kakarala, Van Andel Institute, Grand Rapids, MI and Janette K Merrill and Dana S Wollins, American Society of Clinical Oncology, Alexandria, VA
    J Clin Oncol 32:3568-74. 2014
  5. doi request reprint Lifestyle factors in cancer survivorship
    Jennifer Ligibel
    Dana Farber Cancer Institute, Boston, MA 02215, USA
    J Clin Oncol 30:3697-704. 2012
  6. pmc Patterns of bone density evaluation in a community population treated with aromatase inhibitors
    Jennifer A Ligibel
    Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA
    Breast Cancer Res Treat 134:1305-13. 2012
  7. pmc Impact of a telephone-based physical activity intervention upon exercise behaviors and fitness in cancer survivors enrolled in a cooperative group setting
    Jennifer A Ligibel
    Dana Farber Cancer Institute, 450 Brookline Ave Boston, Boston, MA 02215, USA
    Breast Cancer Res Treat 132:205-13. 2012
  8. doi request reprint Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors
    Jennifer A Ligibel
    Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, Channing Laboratory, Boston, MA, USA
    J Clin Oncol 26:907-12. 2008
  9. ncbi request reprint Role of adjuvant and posttreatment exercise programs in breast health
    Jennifer A Ligibel
    Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA
    J Natl Compr Canc Netw 9:251-6. 2011
  10. pmc Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions
    Jennifer A Ligibel
    Harvard Medical School, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, Massachusetts, USA
    Breast Cancer Res 7:255-7. 2005

Detail Information

Publications33

  1. ncbi request reprint Obesity and breast cancer
    Jennifer Ligibel
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA
    Oncology (Williston Park) 25:994-1000. 2011
    ....
  2. pmc Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance)
    Jennifer A Ligibel
    Dana Farber Cancer Institute, Boston, MA JAL, EW Alliance Statistics and Data Center, Durham, NC CTC Mayo Clinic, Rochester, MN ML, JNI Hofstra North Shore LIJ School of Medicine, ProHEALTH Care Associates, Lake Success, NY MC Northwestern University Feinberg School of Medicine, Chicago, IL WG The Angeles Clinic and Research Institute, Santa Monica, CA SM Rhode Island Hospital, Providence, RI WS St Barnabas Medical Center, Livingston, NJ RM The Genome Institute, Washington University in St Louis, St Louis, MO EM Department of Genetics, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC CMP Breast Cancer Program, Siteman Cancer Center and Washington University School of Medicine, St Louis, MO ME Memorial Sloan Kettering Cancer Center, New York, NY CAH Alliance Statistics and Data Center, MD Anderson Cancer Center, Houston, TX DB Alliance Statistics and Data Center, Dana Farber Cancer Institute, Boston, MA WTB
    J Natl Cancer Inst 107:. 2015
    ..Obesity at diagnosis is associated with poor prognosis in women with breast cancer, but few reports have been adjusted for treatment factors...
  3. doi request reprint Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology Statement
    Jennifer A Ligibel
    Jennifer A Ligibel and Elizabeth S Frank, Dana Farber Cancer Institute, Boston, MA Catherine M Alfano, Elvan C Daniels, and Kevin D Stein, American Cancer Society, Atlanta, GA Dawn Hershman, Columbia University Clifford A Hudis, Memorial Sloan Kettering Cancer Center, New York, NY Rachel M Ballard, National Institutes of Health Worta McCaskill Stevens and Lori M Minasian, National Cancer Institute, Bethesda, MD Suanna S Bruinooge and Laura A Levit, American Society of Clinical Oncology, Alexandria, VA Kerry S Courneya, University of Alberta, Edmonton, Alberta Pamela J Goodwin, University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada Wendy Demark Wahnefried, University of Alabama at Birmingham, Birmingham, AL Melinda L Irwin, Yale School of Public Health, New Haven, CT Mark A O Rourke, Greenville Hospital System, Greenville, SC John P Pierce, University of California San Diego Moores Cancer Center, San Diego, CA and Cynthia A Thomson, University of Arizona, Tucson, AZ
    J Clin Oncol 33:3961-7. 2015
    ....
  4. pmc American Society of Clinical Oncology position statement on obesity and cancer
    Jennifer A Ligibel
    Jennifer A Ligibel, Dana Farber Cancer Institute, Boston, MA Catherine M Alfano, National Cancer Institute, Bethesda, MD Kerry S Courneya, University of Alberta, Edmonton, Alberta, Canada Wendy Demark Wahnefried, University of Alabama at Birmingham, Birmingham, AL Robert A Burger, University of Pennsylvania, Philadelphia, PA Rowan T Chlebowski, Harbor University of California Los Angeles Medical Center, Torrance, CA Carol J Fabian, University of Kansas Medical Center, Westwood, KS Ayca Gucalp, Lee W Jones, and Clifford A Hudis, Memorial Sloan Kettering Cancer Center Dawn L Hershman, Columbia University Medical Center, New York, NY Melissa M Hudson and Kirsten K Ness, St Jude Children s Research Hospital, Memphis, TN Madhuri Kakarala, Van Andel Institute, Grand Rapids, MI and Janette K Merrill and Dana S Wollins, American Society of Clinical Oncology, Alexandria, VA
    J Clin Oncol 32:3568-74. 2014
    ....
  5. doi request reprint Lifestyle factors in cancer survivorship
    Jennifer Ligibel
    Dana Farber Cancer Institute, Boston, MA 02215, USA
    J Clin Oncol 30:3697-704. 2012
    ..This article reviews the evidence that links lifestyle factors to cancer outcomes, provides clinical recommendations for cancer survivors, and describes future directions for lifestyle research in cancer survivors...
  6. pmc Patterns of bone density evaluation in a community population treated with aromatase inhibitors
    Jennifer A Ligibel
    Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA
    Breast Cancer Res Treat 134:1305-13. 2012
    ..Attention is needed to insure that unnecessary fractures are avoided in breast cancer patients taking AIs...
  7. pmc Impact of a telephone-based physical activity intervention upon exercise behaviors and fitness in cancer survivors enrolled in a cooperative group setting
    Jennifer A Ligibel
    Dana Farber Cancer Institute, 450 Brookline Ave Boston, Boston, MA 02215, USA
    Breast Cancer Res Treat 132:205-13. 2012
    ..Lifestyle intervention research is feasible in a cooperative group setting...
  8. doi request reprint Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors
    Jennifer A Ligibel
    Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, Channing Laboratory, Boston, MA, USA
    J Clin Oncol 26:907-12. 2008
    ..We sought to analyze whether exercise lowered insulin concentrations in breast cancer survivors...
  9. ncbi request reprint Role of adjuvant and posttreatment exercise programs in breast health
    Jennifer A Ligibel
    Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA
    J Natl Compr Canc Netw 9:251-6. 2011
    ..This article reviews the growing evidence that exercise could be an important part of breast cancer survivorship, and describes current exercise guidelines for breast cancer survivors...
  10. pmc Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions
    Jennifer A Ligibel
    Harvard Medical School, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, Massachusetts, USA
    Breast Cancer Res 7:255-7. 2005
    ..Ongoing trials will compare these approaches and guide the use of these agents in the years to come...
  11. doi request reprint Physical and psychological outcomes among women in a telephone-based exercise intervention during adjuvant therapy for early stage breast cancer
    Jennifer A Ligibel
    Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA
    J Womens Health (Larchmt) 19:1553-9. 2010
    ..Studies have suggested that decreases in physical activity during treatment may contribute to weight gain in breast cancer patients...
  12. doi request reprint Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivors
    Jennifer A Ligibel
    Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA
    Cancer Causes Control 20:1523-8. 2009
    ..This study examines the impact of exercise upon levels of adiponectin, high molecular weight adiponectin (HMWA), and leptin in breast cancer survivors...
  13. doi request reprint Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ
    Jennifer A Ligibel
    Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
    Ann Surg Oncol 16:106-12. 2009
    ..Women who underwent mastectomy, as well as women who were more anxious, were more likely to decrease their level of physical activity. Women with DCIS might benefit from targeted interventions to increase physical activity...
  14. doi request reprint Randomized trial of a physical activity intervention in women with metastatic breast cancer
    Jennifer A Ligibel
    Breast Oncology Center, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts
    Cancer 122:1169-77. 2016
    ....
  15. pmc Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32
    Pamela J Goodwin
    Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada PJG NCIC Clinical Trials Group, Cancer Research Institute, Queen s University, Kingston, Ontario, Canada WRP, LES, BEC NCIC Clinical Trials Group, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada KAG Dana Farber Cancer Institute, Harvard Medical School, Boston, MA JAL Columbia University Medical Center, New York, NY DLH National Surgical Adjuvant Breast and Bowel Project, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA PR Vanderbilt Ingram Medical Center, Vanderbilt University Medical Center, Nashville, TN IAM Mayo Clinic College of Medicine, Rochester, MN TJH Centre de recherche du CHU de Québec, Unité de recherche en santé des populations Hôpital du Saint Sacrement, Quebec, Quebec, Canada JL National Cancer Research Institute Breast Clinical Studies Group, London, UK AMT Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Ontario, Canada KIP Juravinski Cancer Center at Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada TJW, SDM Allan Blair Cancer Centre, Canada
    J Natl Cancer Inst 107:. 2015
    ....
  16. pmc Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer
    Joseph A Sparano
    Joseph A Sparano, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY Fengmin Zhao and Jennifer A Ligibel, Dana Farber Cancer Institute Harvard University, Boston, MA Silvana Martino, John Wayne Cancer Institute, Santa Monica, CA Edith A Perez, Mayo Clinic, Jacksonville, FL Tom Saphner, Vince Lombardi Cancer Center, Two Rivers, WI Antonio C Wolff, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD George W Sledge Jr, Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN William C Wood, Winship Cancer Center, Emory University, Atlanta, GA and Nancy E Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA
    J Clin Oncol 33:2353-60. 2015
    ..To determine long-term outcomes in a clinical trial evaluating the role of taxane type and schedule in operable breast cancer and evaluate the impact of obesity and black race on outcome...
  17. doi request reprint Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patients
    Jennifer A Ligibel
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA, USA
    Breast Cancer Res Treat 131:589-97. 2012
    ..The side effect profile of AIs in this community-based population was similar to that seen in clinical trials. These findings provide reassurance that AIs appear to be associated with few serious side effects...
  18. pmc The role of obesity in cancer survival and recurrence
    Wendy Demark-Wahnefried
    Department of Nutrition Sciences, University of Alabama at Birmingham, Alabama 35294, USA
    Cancer Epidemiol Biomarkers Prev 21:1244-59. 2012
    ....
  19. doi request reprint A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases
    Nancy U Lin
    Harvard Medical School, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA
    Breast Cancer Res Treat 142:405-14. 2013
    ..Given the high ORR, concurrent lapatinib-WBRT could still be considered for future study with careful safety monitoring. ..
  20. pmc A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases
    Rachel A Freedman
    Department of Medical Oncology, Dana Farber Cancer Institute, 44 Binney Street, Harvard Medical School, Boston, MA 02115, USA
    Clin Breast Cancer 11:376-83. 2011
    ..We observed modest activity with a central nervous system objective response rate of 13.3%; however, median PFS was disappointing. Further studies should focus on other agents to treat this challenging clinical problem...
  21. ncbi request reprint Clinical differences among the aromatase inhibitors
    Jennifer A Ligibel
    Harvard Medical School, Women s Hospital, Boston, Massachusetts 02115, USA
    Clin Cancer Res 9:473S-9S. 2003
    ..This article explores the efficacy and tolerability of the aromatase inhibitors in both the metastatic and the adjuvant settings...
  22. doi request reprint Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents
    Pamela J Goodwin
    Department of Medicine, Division of Clinical Epidemiology at the Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada
    Breast Cancer Res Treat 126:215-20. 2011
    ..32) that has recently been initiated...
  23. doi request reprint Practical clinical interventions for diet, physical activity, and weight control in cancer survivors
    Wendy Demark-Wahnefried
    Professor of Nutrition Sciences, Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, Alabama
    CA Cancer J Clin 65:167-89. 2015
    ....
  24. pmc Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer
    Joseph A Sparano
    Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA
    Cancer 118:5937-46. 2012
    ..Obesity has been associated with inferior outcomes in operable breast cancer, but the relation between body mass index (BMI) and outcomes by breast cancer subtype has not been previously evaluated...
  25. pmc The 2011-2016 Transdisciplinary Research on Energetics and Cancer (TREC) initiative: rationale and design
    Ruth E Patterson
    University of California, San Diego, La Jolla, CA, USA
    Cancer Causes Control 24:695-704. 2013
    ..Recognition of the complex, multidimensional relationship between excess adiposity and cancer control outcomes has motivated the scientific community to seek new research models and paradigms...
  26. pmc Impact of diabetes on oncologic outcome of colorectal cancer patients: colon vs. rectal cancer
    Justin Y Jeon
    Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
    PLoS ONE 8:e55196. 2013
    ..To evaluate the impact of diabetes on outcomes in colorectal cancer patients and to examine whether this association varies by the location of tumor (colon vs. rectum)...
  27. ncbi request reprint New NCCN guidelines for survivorship care
    Jennifer A Ligibel
    Department of Medicine, Harvard Medical School, and Adult Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA jligibel partners org
    J Natl Compr Canc Netw 11:640-4. 2013
    ..They also discuss implementing new recommendations on survivorship assessment in the clinic...
  28. doi request reprint Mucinous breast carcinoma: a large contemporary series
    Christina R Barkley
    Department of Surgery, Brigham and Women s Hospital, Boston, MA, USA
    Am J Surg 196:549-51. 2008
    ..Mucinous breast cancer is typically associated with a favorable prognosis. This study aimed to assess recent trends and prognostic features in the treatment of mucinous breast carcinoma...
  29. ncbi request reprint Body Mass Index and Locoregional Recurrence in Women with Early-Stage Breast Cancer
    Laura E G Warren
    Harvard Radiation Oncology Program, Boston, MA, USA
    Ann Surg Oncol 23:3870-3879. 2016
    ..However, the relationship between BMI and locoregional recurrence (LRR) has been less well studied and was therefore the subject of this investigation...
  30. doi request reprint Effect of the LIVESTRONG at the YMCA exercise program on physical activity, fitness, quality of life, and fatigue in cancer survivors
    Melinda L Irwin
    Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut
    Cancer . 2016
    ....
  31. doi request reprint Randomized trial of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: the LISA trial
    Pamela J Goodwin
    Pamela J Goodwin, Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital and Princess Margaret Hospital Kathleen I Pritchard, Sunnybrook Odette Cancer Center Pamela J Goodwin and Kathleen I Pritchard, University of Toronto, Toronto Roanne J Segal, Ottawa Hospital Regional Cancer Center, University of Ottawa, Ottawa Gregory R Pond, Som Mukherjee, and Mark Levine, Juravinski Hospital and Cancer Center Brian Findlay, Niagara Health System, Walker Family Cancer Center Gregory R Pond, Mark Levine, Brian Findlay, and Som Mukherjee, McMaster University, Hamilton, Ontario Michael Vallis, Dalhousie University, Halifax, Nova Scotia André Robidoux, Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada Jennifer A Ligibel, Dana Farber Cancer Institute George L Blackburn, Beth Israel Deaconess Medical Center Jennifer A Ligibel and George L Blackburn, Harvard Medical School, Boston, MA and Julie R Gralow, University of Washington, Seattle, WA
    J Clin Oncol 32:2231-9. 2014
    ..Obesity is associated with poor outcomes in women with operable breast cancer. Lifestyle interventions (LIs) that help women reduce their weight may improve outcomes...
  32. pmc Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation
    Julienne E Bower
    Julienne E Bower and Patricia A Ganz, University of California at Los Angeles, Los Angeles, CA Kate Bak and Christina Lacchetti, American Society of Clinical Oncology, Alexandria, VA Ann Berger, National Institutes of Health Clinical Center, Bethesda, MD William Breitbart, Memorial Sloan Kettering Cancer Center, New York, NY Carmelita P Escalante, University of Texas MD Anderson Cancer Center, Houston, TX Hester Hill Schnipper, Beth Israel Deaconess Medical Center Jennifer A Ligibel, Dana Farber Cancer Institute William F Pirl, Massachusetts General Hospital, Boston, MA Gary H Lyman, Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA Mohammed S Ogaily, Oakwood Center for Hematology and Oncology Downriver, Brownstown, MI and Paul B Jacobsen, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
    J Clin Oncol 32:1840-50. 2014
    ..This guideline presents screening, assessment, and treatment approaches for the management of adult cancer survivors who are experiencing symptoms of fatigue after completion of primary treatment...
  33. ncbi request reprint Trastuzumab/chemotherapy combinations in metastatic breast cancer
    Jennifer A Ligibel
    Harvard Medical School, Boston, MA 02115, USA
    Semin Oncol 29:38-43. 2002
    ....